Previous work in pancreatic ductal adenocarcinoma cells identified TTLL4 as an interaction partner of PELP1, and knockdown of TTLL4 was shown to reduce glutamylation levels of the PELP1 GAR and subsequently decrease PELP1 association with histone H3 (52). Here, TTLL4 is linked to pancreatic ductal adenocarcinoma.